[1]
Belančić, A. et al. 2026. Off-Label Use of SGLT2 Inhibitors for Weight Loss— We Must Not Open That Pandora’s Box!. Annals of Biomedical and Clinical Research. 5, 1 (Jul. 2026), 74–77.